ClinicalTrials.gov
public full text
Public Domain
Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma
The purpose of this study is to evaluate the safety and CTL reaction of novel peptide vaccination for advanced renal cell carcinoma
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma#1150455
- Study of Specific CD4 Tumors Th1 Responses in Renal Transplant After Occurrence of Cancer#1033004
- Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors#1030970
- AminoMedixTM for Kidney Protection During Radionuclide Therapy#1088399
- Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors#864988
Record · ID 878757
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive